PCM
NVO

Penserra Capital Management’s Novo Nordisk NVO Stock Holding History

Penserra Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$425K Sell
8,881
-4,550
-34% -$195K ﹤0.01% 601
2026
Q1 		$493K Buy
13,431
+6,626
+97% +$314K 0.01% 561
2025
Q4 		$346K Sell
6,805
-87
-1% -$4.45K ﹤0.01% 588
2025
Q3 		$382K Buy
6,892
+2,144
+45% +$125K ﹤0.01% 618
2025
Q2 		$327K Sell
4,748
-3,083
-39% -$210K ﹤0.01% 560
2025
Q1 		$543K Buy
7,831
+1,794
+30% +$148K 0.01% 580
2024
Q4 		$519K Buy
6,037
+618
+11% +$66.8K 0.01% 559
2024
Q3 		$645K Sell
5,419
-40,913
-88% -$5.46M 0.01% 497
2024
Q2 		$6.61M Buy
46,332
+15,762
+52% +$2.09M 0.08% 196
2024
Q1 		$3.92M Buy
30,570
+23,006
+304% +$2.74M 0.05% 259
2023
Q4 		$782K Sell
7,564
-20,769
-73% -$2.05M 0.01% 422
2023
Q3 		$2.58M Buy
+28,333
New +$2.5M 0.05% 231
2023
Q2 		– Sell
-8,052
Closed -$640K – 1303
2023
Q1 		$640K Buy
8,052
+5,856
+267% +$415K 0.01% 446
2022
Q4 		$148K Buy
2,196
+1,464
+200% +$85.8K ﹤0.01% 745
2022
Q3 		$36K Buy
+732
New +$39.2K ﹤0.01% 841

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Penserra Capital Management's NVO Position: Q2 2026 in Review

Penserra Capital Management reduced its Novo Nordisk (NVO) stake by 34% in Q2 2026, selling an estimated $195K and leaving 8,881 shares worth $425K. The position accounts for ﹤0.01% of the portfolio, ranked #601.

Penserra Capital Management first reported a position in NVO in Q3 2022 and has held it in 15 quarters since. The position peaked at $6.61M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Penserra Capital Management held 8,881 shares of Novo Nordisk worth $425K as of Q2 2026.
  • Penserra Capital Management sold 4,550 Novo Nordisk shares in Q2 2026, an estimated $195K.
  • Novo Nordisk made up ﹤0.01% of Penserra Capital Management's portfolio in Q2 2026, its #601 holding.
  • Penserra Capital Management first reported a position in Novo Nordisk in Q3 2022 and has held it in 15 quarters since.
  • Penserra Capital Management's Novo Nordisk position peaked at $6.61M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.